Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology

Next-generation sequencing (NGS) technology is capable of sequencing millions or billions of DNA molecules simultaneously. Therefore, it represents a promising tool for the analysis of molecular targets for the initial diagnosis of disease, monitoring of disease progression, and identifying the mech...

Full description

Bibliographic Details
Main Authors: Xuchao Zhang, Zhiyong Liang, Shengyue Wang, Shun Lu, Yong Song, Ying Cheng, Jianming Ying, Weiping Liu, Yingyong Hou, Yangqiu Li, Yi Liu, Jun Hou, Xiufeng Liu, Jianyong Shao, Yanhong Tai, Zheng Wang, Li Fu, Hui Li, Xiaojun Zhou, Hua Bai, Mengzhao Wang, You Lu, Jinji Yang, Wenzhao Zhong, Qing Zhou, Xuening Yang, Jie Wang, Cheng Huang, Xiaoqing Liu, Xiaoyan Zhou, Shirong Zhang, Hongxia Tian, Yu Chen, Ruibao Ren, Ning Liao, Chunyan Wu, Zhongzheng Zhu, Hongming Pan, Yanhong Gu, Liwei Wang, Yunpeng Liu, Suzhan Zhang, Tianshu Liu, Gong Chen, Zhimin Shao, Binghe Xu, Qingyuan Zhang, Ruihua Xu, Lin Shen, Yilong Wu, On behalf of Chinese Society of Clinical Oncology (CSCO) Tumor Biomarker Committee
Format: Article
Language:English
Published: China Anti-Cancer Association 2019-03-01
Series:Cancer Biology & Medicine
Subjects:
Next-generation sequencing technology
cancer
consensus
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1361

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/1361

Similar Items